Oxidative stress and defective platelet apoptosis in naïve patients with Kawasaki disease.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2010-02-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbrc.2010.01.040PMID 20079717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of oxidative and nitrosative stress biomarkers in chronic heart failure.

  2009cited by this paper
• Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis?

  2009cited by this paper
• IVIG reduced vascular oxidative stress in patients with Kawasaki disease.

  2009cited by this paper
• Increased nitric oxide production by neutrophils in early stage of Kawasaki disease

  2009cited by this paper
• Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function.

  2009cited by this paper
• Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents

  2009cited by this paper
• Recognition of a Kawasaki Disease Shock Syndrome

  2009cited by this paper
• Coronary artery noninvasive imaging in adult Kawasaki disease.

  2009cited by this paper
• Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A – activation and long‐term commitment to cell death

  2009cited by this paper
• Kawasaki disease in children

  2008cited by this paper
• Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness

  2008cited by this paper
• Kawasaki disease: an overview

  2008cited by this paper
• Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight

  2008cited by this paper
• Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization.

  2008cited by this paper
• The increase in human plasma antioxidant capacity after red wine consumption is due to both plasma urate and wine polyphenols.

  2008cited by this paper
• Long-term outcome of Kawasaki disease.

  2008cited by this paper
• Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis.

  2008cited by this paper
• Methods for distinguishing apoptotic from necrotic cells and measuring their clearance.

  2008cited by this paper
• Circulating P-selectin and the risk of recurrent venous thromboembolism

  2007cited by this paper
• The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease

  2007cited by this paper
• BMC Pediatrics BioMed Central

  2006cited by this paper
• TNF-α Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease1

  2006cited by this paper
• Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor--evidence from epidemiological and prospective clinical trials.

  2006cited by this paper
• Extreme Thrombocytosis Predicts Kawasaki Disease in Infants

  2006cited by this paper
• Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease

  2005cited by this paper
• Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease

  2004cited by this paper
• P‐selectin in haemostasis

  2004cited by this paper
• Clinical significance of measurement of plasma annexin V concentration of patients in the emergency room.

  2003cited by this paper
• Spontaneous platelet aggregation in Kawasaki disease using the particle counting method

  2003cited by this paper
• Association of Asymmetric Dimethylarginine and Endothelial Dysfunction

  2003cited by this paper
• A Journey with Platelet P-Selectin: The Molecular Basis of Granule Secretion, Signalling and Cell Adhesion

  2001cited by this paper
• Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease.

  2000cited by this paper
• CD14+CD16+ monocyte subpopulation in Kawasaki disease

  2000cited by this paper
• HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Role of Caspase in a Subset of Human Platelet Activation Responses

  1999cited by this paper
• Role of caspase in a subset of human platelet activation responses.

  1999cited by this paper
• Circulating soluble selectins in Kawasaki disease

  1997cited by this paper
• Superoxide release by human polymorphonuclear leukocytes in the presence of deferoxamine.

  1997cited by this paper
• Fibroblast growth and polymorphonuclear granulocyte activation in the presence of a new biologically active sol–gel glass

  1997cited by this paper
• Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X

  1997cited by this paper
• Alterations in Bcl‐2/Bax protein levels in platelets form part of an ionomycin‐induced process that resembles apoptosis

  1997cited by this paper
• Superoxide production by neutrophils in children with malignant tumors treated with recombinant human granulocyte colony-stimulating factor.

  1995cited by this paper
• Diagnosis?

  1987cited by this paper
• AN ANIMAL MODEL OF KAWASAKI DISEASE

  1984cited by this paper
• A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

  1974cited by this paper

• Asymmetric dimethylarginine as a predictive marker for resistance to high-dose intravenous immunoglobulin in Kawasaki disease

  2025cites this paper
• Platelets in Kawasaki disease: mediators of vascular inflammation

  2024influential citation
• Phytochemicals profiling of Cassia fistula fruit extract and its effect on serum lipids and hematological parameters in high‐fat diet‐induced hyperlipidemic female rats

  2024cites this paper
• VAERS Vasculitis Adverse Events Retrospective Study: Etiology Model of Immune Complexes Activating Fc Receptors in Kawasaki Disease and Multisystem Inflammatory Syndromes

  2024cites this paper
• [Recent research on platelet-leukocyte aggregates and their role in the pathogenesis of Kawasaki disease].

  2023cites this paper
• Roles of Oxidative Injury and Nitric Oxide System Derangements in Kawasaki Disease Pathogenesis: A Systematic Review

  2023cites this paper
• Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis

  2023cites this paper
• Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease

  2022cites this paper
• Pediatric Multisystem Syndrome Associated with SARS-CoV-2 (MIS-C): The Interplay of Oxidative Stress and Inflammation

  2022cites this paper
• Filamin A regulates caspase-3 cleavage in platelets in a protein kinase C (PKC)-dependent manner.

  2022cites this paper
• Assessment of Endothelial Dysfunction in Patients with Kawasaki Disease: A Meta-Analysis

  2022cites this paper
• Activation of STING facilitates Kawasaki disease through mediating inflammation and apoptosis

  2021cites this paper
• Multisystem Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Role of Oxidative Stress

  2021cites this paper
• The relationship between TNF-like protein 1A and coronary artery aneurysms in children with Kawasaki disease

  2021cites this paper
• Single-nucleotide Polymorphism rs17860041 A/C in the Promoter of the PPIA Gene is Associated with Susceptibility to Kawasaki Disease in Chinese Children

  2020cites this paper
• Sex differences in blood pro-oxidant status and platelet activation in children admitted with respiratory syncytial virus bronchiolitis: a pilot study

  2020cites this paper
• Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease

  2020cites this paper
• The Role of T-cell Costimulation in the Pathogenesis of Kawasaki Disease

  2019cites this paper
• P2RY12:rs7637803 TT variant genotype increases coronary artery aneurysm risk in Kawasaki disease in a southern Chinese population

  2019cites this paper
• Platelets in Kawasaki disease: Is this only a numbers game or something beyond?

  2019cites this paper
• Potential role of platelets for atherosclerotic events in rheumatoid arthritis

  2018cites this paper
• Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase

  2018cites this paper
• Pathogenetic determinants in Kawasaki disease: the haematological point of view

  2017cites this paper
• An Investigation into Gilbert’s Syndrome: Understanding the Role of Unconjugated Bilirubin in Targeting Platelet and Haemostatic Mechanisms Associated with Thrombotic Risk Factors

  2017cites this paper
• Antiplatelet and Anticoagulant Therapies for Kawasaki Disease: Theory and Practice

  2017cites this paper
• Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease

  2017cites this paper
• Possible Implication of Red Blood Cells in the Prothrombotic Risk in Early Rheumatoid Arthritis

  2015cites this paper
• In Vitro Susceptibility of Wistar Rat Platelets to Hydrogen Peroxide and AAPH-Induced Oxidative Stress

  2015cites this paper
• Biologicals, platelet apoptosis and human diseases: An outlook.

  2015cites this paper
• Red blood cells as bioindicators of cardiovascular risk in Kawasaki disease: A case report.

  2015cites this paper
• Redox Control of Platelet Functions in Physiology and Pathophysiology

  2014cites this paper
• Asymmetric and symmetric dimethylarginine are associated with coronary artery lesions in Kawasaki disease.

  2014cites this paper
• Platelets in Kawasaki patients: two different populations with different mitochondrial functions.

  2014cites this paper
• Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology

  2014cites this paper
• Differential action of phytochemicals on platelet apoptosis: a biological overview.

  2013cites this paper
• Comparison of the Laboratory Data Between Kawasaki Disease and Enterovirus After Intravenous Immunoglobulin Treatment

  2012cites this paper
• Regulation of Oxidative Stress in Patients with Kawasaki Disease

  2012cites this paper
• Does Oxidative Stress Play a Critical Role in Cardiovascular Complications of Kawasaki Disease?

  2012cites this paper
• Abstract O.27: The Role Of CD40L And CD40 In The Pathogenesis Of Kawasaki Disease

  2011cites this paper
• Elevated plasma advanced oxidation protein products in children with Henoch–Schonlein purpura

  2011cites this paper
• Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology

  2010cites this paper